6 completed, 3 active not recruiting, 3 recruiting. 4 Phase 2, 3 Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Not applicable | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow Ganglioglioma: new trials by email Literature Review of Ganglioglioma trials Research Report on Ganglioglioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach Amygdalo-Hippocampectomy - Hippocampal Sclerosis, Dysembryoplastic Neuroepithelial Tumor | Recruiting | University Hospital, Montpellier | 3504 | 2024-08-31 | 2025-04-08 | |
| SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma Mirdametinib - Low-Grade Glioma, Recurrent Low-Grade Glioma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 132 | 2021-06-21 | 2026-09-11 |
| Pediatric Long-Term Follow-up and Rollover Study dabrafenib, trametinib - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 163 | 2019-11-04 | 2026-08-27 |
| Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma Hippocampal-avoidance proton therapy - Glioma, Pilocytic Astrocytoma | Not applicable | Active not recruiting | St. Jude Children's Research Hospital | 48 | 2019-08-28 | 2026-09-15 |
| Social Determinants of Health in Glioblastoma Population Part 1 Survey Group, Part 2 Focus Group - Glioma, Astrocytoma | Completed | Wake Forest University Health Sciences | 100 | 2019-05-22 | 2026-08-03 | |
| Intraoperative Fluorescence of Ganglogliomas and Neuroepithelial Dysembryoplastic Tumors Surgical Procedure, Unspecified | Completed | Rennes University Hospital | 7 | 2018-07-15 | 2019-06-04 | |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology ProTRAIT - Astrocytoma, Ependymoma | Recruiting | Maastricht Radiation Oncology | 1500 | 2018-01-01 | 2026-10-13 | |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors Dabrafenib, trametinib, Carboplatin - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 2 | Completed | Novartis Pharmaceuticals | 151 | 2017-12-28 | 2023-12-13 |
| A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 rQNestin, Cyclophosphamide, Stereotactic biopsy - Malignant Glioma of Brain, Astrocytoma | Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 62 | 2017-07-18 | 2026-03-04 |
| Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors Irinotecan, Bevacizumab, FDOPA-PET/MRI imaging - Astrocytoma, Oligoastrocytoma, Mixed, Ganglioneuroma | Phase 1 | Completed | Washington University School of Medicine | 6 | 2013-04-01 | 2016-10-21 |
| Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation Proton radiotherapy - Brain Tumor, Low Grade Glioma | Phase 2 | Completed | Massachusetts General Hospital | 100 | 2011-02-01 | 2025-06-03 |
| Antineoplaston Therapy in Treating Children With Brain Tumors Antineoplaston therapy (Atengenal + Astugenal) - Childhood Brain Tumors | Phase 2 | Completed | Burzynski Research Institute | 34 | 1996-09-01 | 2022-03-07 |
Astrocytoma (11) · Oligodendroglioma (7) · Glioma (6) · Ependymoma (4) · Ganglioneuroma (4) · Glioblastoma (4) · Neurocytoma (4) · Brain Neoplasms (2) · Craniopharyngioma (2) · Adenoma (1) · Disease (1) · Epidermal Cyst (1) · Germinoma (1) · Gliosarcoma (1)
Neoplasms (12) · Neoplasms by Histologic Type (12) · Neoplasms, Germ Cell and Embryonal (12) · Neoplasms, Glandular and Epithelial (12) · Neoplasms, Nerve Tissue (12) · Neuroectodermal Tumors (12) · Neoplasms, Neuroepithelial (11) · Nervous System Diseases (8) · Central Nervous System Neoplasms (7) · Neoplasms by Site (7) · Nervous System Neoplasms (7) · Brain Diseases (6) · Central Nervous System Diseases (6) · Glioma (6) · Brain Neoplasms (4)
dabrafenib (2) · trametinib (2) · Bevacizumab (1) · Carboplatin (1) · Cyclophosphamide (1) · Irinotecan (1) · Vincristine (1) · antineoplaston A10 (1) · antineoplaston AS 2-1 (1) · mirdametinib (1)
Novartis Pharmaceuticals (2) · St. Jude Children's Research Hospital (2) · Burzynski Research Institute (1) · Dana-Farber Cancer Institute (1) · Maastricht Radiation Oncology (1) · Massachusetts General Hospital (1) · Rennes University Hospital (1) · University Hospital, Montpellier (1) · Wake Forest University Health Sciences (1) · Washington University School of Medicine (1)
United States (9) · France (4) · Netherlands (3) · Argentina (2) · Australia (2) · Belgium (2) · Brazil (2) · Canada (2) · Czechia (2) · Denmark (2) · Finland (2) · Germany (2) · Israel (2) · Italy (2) · Japan (2)
A Mendez Romero (1) · Anna Vinitsky, MD, MS (1) · Danielle Eekers (1) · E. Antonio Chiocca, MD, PhD (1) · Giles W. Robinson, MD (1) · Hiske van der Weide (1) · I Coremans (1) · Inge Compter (1) · J Jaspers (1) · Jaap Zindler (1) · Karen Gauvain, M.D. (1) · M Kramer (1) · M Kroesen (1)
PMID 30118397, PMID 32373649, PMID 34331515, PMID 35022322, PMID 37610803, PMID 37643378, PMID 37733309, PMID 37853118, PMID 38853689, PMID 41679299, PMID 41740060
2015 (1), 2023 (1)